These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26456124)

  • 41. Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.
    Nehs MA; Nagarkatti S; Nucera C; Hodin RA; Parangi S
    Surgery; 2010 Dec; 148(6):1154-62; discussion 1162. PubMed ID: 21134546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.
    Pishkari S; Paryan M; Hashemi M; Baldini E; Mohammadi-Yeganeh S
    J Endocrinol Invest; 2018 Mar; 41(3):269-283. PubMed ID: 28762013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation of aggressive tumor progression of anaplastic thyroid cancer by p53.
    Hwang E; Kruhlak M; Wong N; Chari R; Kimura T; Cheng SY
    Am J Cancer Res; 2024; 14(9):4429-4444. PubMed ID: 39417187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel orthotopic mouse model of human anaplastic thyroid carcinoma.
    Nucera C; Nehs MA; Mekel M; Zhang X; Hodin R; Lawler J; Nose V; Parangi S
    Thyroid; 2009 Oct; 19(10):1077-84. PubMed ID: 19772429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancer.
    Liu B; Peng Y; Su Y; Diao C; Qian J; Zhan X; Cheng R
    Anticancer Drugs; 2024 Sep; 35(8):741-751. PubMed ID: 38820067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR18a and miR19a Recruit Specific Proteins for Splicing in Thyroid Cancer Cells.
    Paiva MM; Kimura ET; Coltri PP
    Cancer Genomics Proteomics; 2017; 14(5):373-381. PubMed ID: 28871004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells.
    Fan M; Li X; Jiang W; Huang Y; Li J; Wang Z
    Exp Ther Med; 2013 Apr; 5(4):1143-1146. PubMed ID: 23599737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space.
    Wise PM; Neviani P; Riwaldt S; Corydon TJ; Wehland M; Braun M; Krüger M; Infanger M; Grimm D
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene master regulators of papillary and anaplastic thyroid cancers.
    Iacobas DA; Tuli NY; Iacobas S; Rasamny JK; Moscatello A; Geliebter J; Tiwari RK
    Oncotarget; 2018 Jan; 9(2):2410-2424. PubMed ID: 29416781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysis.
    Galdiero F; Bello AM; Spina A; Capiluongo A; Liuu S; De Marco M; Rosati A; Capunzo M; Napolitano M; Vuttariello E; Monaco M; Califano D; Turco MC; Chiappetta G; Vinh J; Chiappetta G
    Oncotarget; 2018 Jan; 9(8):8016-8026. PubMed ID: 29487711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Gene Master Regulators (GMR) Approach Provides Legitimate Targets for Personalized, Time-Sensitive Cancer Gene Therapy.
    Iacobas S; Ede N; Iacobas DA
    Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31349573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma.
    Lubitz CC; Parangi S; Holm TM; Bernasconi MJ; Schalck AP; Suh H; Economopoulos KP; Gunda V; Donovan SE; Sadow PM; Wirth LJ; Sullivan RJ; Panka DJ
    J Mol Diagn; 2016 Jan; 18(1):100-8. PubMed ID: 26631873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
    Geraldo MV; Kimura ET
    PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Influence of Patient Age on Thyroid Nodule Formation, Multinodularity, and Thyroid Cancer Risk.
    Kwong N; Medici M; Angell TE; Liu X; Marqusee E; Cibas ES; Krane JF; Barletta JA; Kim MI; Larsen PR; Alexander EK
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4434-40. PubMed ID: 26465395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs.
    Prete A; Matrone A; Gambale C; Torregrossa L; Minaldi E; Romei C; Ciampi R; Molinaro E; Elisei R
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Combinatorial Strategy for Targeting
    Ghosh C; Kumar S; Kushchayeva Y; Gaskins K; Boufraqech M; Wei D; Gara SK; Zhang L; Zhang YQ; Shen M; Mukherjee S; Kebebew E
    Clin Cancer Res; 2020 Apr; 26(8):2022-2036. PubMed ID: 31937621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoencoder Based Feature Selection Method for Classification of Anticancer Drug Response.
    Xu X; Gu H; Wang Y; Wang J; Qin P
    Front Genet; 2019; 10():233. PubMed ID: 30972101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
    Liu C; Feng Z; Chen T; Lv J; Liu P; Jia L; Zhu J; Chen F; Yang C; Deng Z
    Cell Cycle; 2019 Jan; 18(2):167-203. PubMed ID: 30596336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNAs in the thyroid.
    Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
    Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines.
    Varmeh S; Vanden Borre P; Gunda V; Brauner E; Holm T; Wang Y; Sadreyev RI; Parangi S
    Surgery; 2016 Jan; 159(1):152-62. PubMed ID: 26456124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.